Urica Therapeutics, Inc.
Biotechnology company · Bay Harbor Islands, Florida, United States
Urica Therapeutics, Inc. is a biotechnology company headquartered in Bay Harbor Islands, Florida, United States. It has reported private securities offerings to the US SEC, most recently $2.5 million sold in a notice filed in 2023.
Profile compiled from public records. Is this your company? Request a correction or update
Urica Therapeutics at a glance
Typebiotechnology company
HeadquartersBay Harbor Islands, Florida, United States
SEC CIK1959861
What does Urica Therapeutics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $2.5 million sold (2023).
Frequently asked questions about Urica Therapeutics
Where is Urica Therapeutics headquartered?
Urica Therapeutics, Inc. is headquartered in Bay Harbor Islands, Florida, United States.
What does Urica Therapeutics do?
Urica Therapeutics, Inc. is a biotechnology company.
Similar companies
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
- Vaxcyte, Inc.San Carlos, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences